Drugmaker Pfizer cutting up to 800 scientist jobs - washingtonpost.com
"The move comes after the company announced in September it was narrowing its research focus to six disease areas Alzheimer's, cancer, schizophrenia, pain, inflammation and diabetes"...
"Surprisingly, one of the areas abandoned was cardiovascular disease, where Pfizer had been a dominant player with its $13 billion-a-year cholesterol fighter Lipitor, the world's top-selling drug..."
Thursday, January 15, 2009
Why the Pfizer layoff? narrowing its research focus? Cardiovascular research abandoned.
Wednesday, January 14, 2009
More drug approvals from FDA is a welcome sign
More approvals are welcome. Industry accuses FDA for not being efficient. At the same time, one should not forget about incidents like Vioxx tragedy
FDA Approves More Drugs, Still Misses Deadlines
FDA Approves More Drugs, Still Misses Deadlines
Subscribe to:
Posts (Atom)